Evidence map›Paper›PMID 26395476›Full record

ArticleDevelopment (Cambridge, England)2015

A germ cell determinant reveals parallel pathways for germ line development in Caenorhabditis elegans.

Rana Mainpal, Jeremy Nance, Judith L Yanowitz

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Germline stem cells in human.Signal transduction and targeted therapy · 2022
    Review
  10. Article
  11. Proteasomal subunit depletions differentially affect germline integrity inFrontiers in cell and developmental biology · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Rana MainpalMagee-Womens Research Institute, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Jeremy NanceHelen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular Medicine, NYU School of Medicine, New York, NY 10016, USA Department of Cell Biology, NYU School of Medicine, New York, NY 10016, USA.
Judith L YanowitzMagee-Womens Research Institute, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA yanowitzjl@mwri.magee.edu.
University of Pittsburgh · USNew York University · US

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Undergraduate Summer Research Supplement for 5R01GM104007-07: Characterization of a Meiotic Crossover Surveillance SystemR01GM104007 · NIGMS · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI YANOWITZ, JUDITH L · 2013 to 2021
$2.6M
Genetic control of C. elegans gastrulationR21HD058953 · NICHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NANCE, JEREMY · 2009 to 2010
$462k
COELOMOCYTES IN C.ELEGANS--CELL FATE DETERMINATIONF32HD008715 · NICHD · CARNEGIE INSTITUTION OF WASHINGTON, D.C. · PI YANOWITZ, JUDITH L · 2000 to 2002
$112k
NICHD NIH HHS F32 HD008715NICHD NIH HHS R21 HD058953NICHD NIH HHS R21HD058953NIGMS NIH HHS R01 GM104007NIH HHS P40 OD010440
6 · The paper itself

Abstract

Despite the central importance of germ cells for transmission of genetic material, our understanding of the molecular programs that control primordial germ cell (PGC) specification and differentiation are limited. Here, we present findings that X chromosome NonDisjunction factor-1 (XND-1), known for its role in regulating meiotic crossover formation, is an early determinant of germ cell fates in Caenorhabditis elegans. xnd-1 mutant embryos display a novel 'one PGC' phenotype as a result of G2 cell cycle arrest of the P4 blastomere. Larvae and adults display smaller germ lines and reduced brood size consistent with a role for XND-1 in germ cell proliferation. Maternal XND-1 proteins are found in the P4 lineage and are exclusively localized to the nucleus in PGCs, Z2 and Z3. Zygotic XND-1 turns on shortly thereafter, at the ∼300-cell stage, making XND-1 the earliest zygotically expressed gene in worm PGCs. Strikingly, a subset of xnd-1 mutants lack germ cells, a phenotype shared with nos-2, a member of the conserved Nanos family of germline determinants. We generated a nos-2 null allele and show that nos-2; xnd-1 double mutants display synthetic sterility. Further removal of nos-1 leads to almost complete sterility, with the vast majority of animals without germ cells. Sterility in xnd-1 mutants is correlated with an increase in transcriptional activation-associated histone modification and aberrant expression of somatic transgenes. Together, these data strongly suggest that xnd-1 defines a new branch for PGC development that functions redundantly with nos-2 and nos-1 to promote germline fates by maintaining transcriptional quiescence and regulating germ cell proliferation.

Indexed as

Gene Expression Regulation, DevelopmentalAllelesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell CycleCell DifferentiationCell LineageCell NucleusCell ProliferationChromatinEmbryo, NonmammalianG2 PhaseGenotypeGerm CellsMutationCaenorhabditis elegans ProteinsChromatinnos-1 protein, C elegansnos-2 protein, C elegansxnd-1 protein, C elegansC. elegansGerm lineNanosPrimordial germ cellsProliferationXND-1

Identifiers

PMID26395476
PMCPMC6514396
OpenAlexW2234553117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.